Archives: Press Releases

FREDERICK, MD April 13, 2020—Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three (3) pre-clinical studies conducted in beagle dogs. These studies … Read more

Frederick, MD, March 31, 2020 – Velocidy Bio’s Dutch biotech partner, Molecular Biology Systems (MBS), has developed a new method using its revolutionary NEXTGENPCR that decreases the testing time for SARS-CoV-2 to eight minutes, … Read more

Molecular Biology Systems (MBS), the developer of NEXTGENPCR, is pleased to announce their newest distributor, Velocidy Bio. Velocidy Bio becomes the exclusive distributor of NEXTGENPCR instruments, accessories and consumables in … Read more

Frederick, Maryland, – Datakwip, FITCI’s gradaute and a building analytics software company in Frederick, Maryland, was internationally recognized in CEMEX Ventures top 50 most promising start-up companies working in construction … Read more

FREDERICK, Md.— Tellor, a Frederick based blockchain startup, is working to improve upon Ethereum, the world’s leading programmable blockchain, by utilizing proof-of-work miners to complete smart contracts. Tellor, a member … Read more

On November 10, 2019, Mr. Michael Mesa, President, and CEO of Mesa Science Associates (MSA), announced the presentation of a non-clinical study regarding Nasal Administration of Epinephrine. The results were … Read more

FREDERICK, MD. – Eleven startup businesses recently graduated from the Edge, a community growth business accelerator founded late last year by Frederick Innovative Technology Center, Inc. (FITCI) in collaboration with Frederick National … Read more

Frederick, MD – Starting a business is like jumping off a cliff… and building your wings on the way down. That’s why the premiere class of entrepreneurs graduating from The Edge, … Read more

On September 5th FITCI hosted the 11th Annual FITCI/Fort Detrick Alliance Technology Showcase which featured a new partnership with The Maryland Defense Technology Commercialization Center (DefTech). With nearly 200 people in attendance … Read more

FREDERICK, MD – September 5, 2019 – Veralox Therapeutics (“Veralox”), a preclinical stage company focused on accelerating the development of first-in-class therapeutics for unmet medical needs, today announced it has raised … Read more